A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
about
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinomaHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesContributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesisAre hematopoietic stem cells involved in hepatocarcinogenesis?Mouse models of hepatitis B virus infection comprising host-virus immunologic interactionsStealth and cunning: hepatitis B and hepatitis C viruses.Mouse models in liver cancer research: A review of current literatureTowards a small animal model for hepatitis CCD24 polymorphisms affect risk and progression of chronic hepatitis B virus infectionGenetic engineering of a mouse: Dr. Frank Ruddle and somatic cell geneticsTranscriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue.Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.Hepatitis B Virus Immunopathology, Model Systems, and Current TherapiesCimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell.Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice.Hepatitis B virus-induced oncogenesis.La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNAExpression and replication of hepatitis B virus genome in transgenic mice.Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis BPathogenesis of hepatitis B virus infectionThe PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice.New animal models of hepatitis B and C.Multiplex gene regulation: a two-tiered approach to transgene regulation in transgenic mice.Experimental models of hepatocellular carcinomaStructural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic miceHepatocellular carcinoma: insight from animal models.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicityMolecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic miceModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in MiceMolecular characterization of hepatocarcinogenesis using mouse modelsMetal-inducible pathology in the liver, pancreas, and kidney of transgenic mice expressing SV40 early region genes.High-level hepatitis B virus replication in transgenic mice.Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen.The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
P2860
Q24554410-C6A219FE-4F90-471B-BD04-1BB7AB8CFACDQ24563988-6A51BF8A-AB48-4C92-A95B-C45824137101Q26772317-A02B1646-DA7F-400A-9218-C679B0CA7071Q26775804-5CD9FF41-C6D5-42CA-9783-42446482DF56Q26830307-4E69A3E0-7744-49F5-8FBB-B7A1D5FC23D2Q27002598-7EC8DD8F-14ED-4806-9744-C8BAD52ECAA3Q27470232-9E603C40-121E-413C-944D-958CC8C61775Q27490350-80E18FE7-0282-40EE-9503-2549037CCF50Q27490373-8AA5F938-42C9-4CAA-903E-E5A4CE6B0879Q28252325-13CE6CB3-8A72-42E3-A68A-2F26065A1984Q28743531-C84F398C-E360-4A4D-8762-58EBA6D61357Q30661634-7420B1EE-8973-4E90-8F38-4BF7358295EDQ33248641-90232C0A-A2F2-45F6-B97C-843E7DCF2FD6Q33559657-324247D0-ECE2-44C0-9932-25C3C38085CBQ33578026-776EBEA9-AB68-4E9C-B67D-64EC82975755Q33639557-2DC491D4-639F-485E-98F5-384FBEECBA42Q33787553-B79EE1B1-2108-4DAD-9C30-2A21199769DCQ33815588-CC044C0A-8FAB-49DD-875E-2B0325969150Q33828858-A8447C29-4D7A-47B3-968C-25DCE513BE45Q33867720-781F95D7-EF11-440C-83A1-A1DE2EF1CCB2Q33883607-93160A6B-4D79-40A3-AA96-5EFB3BF3A2E3Q33925491-B9C20F47-9234-4530-80F6-3335DAECE7DAQ34085793-CA3DF18D-F0F6-4E1D-88F5-93D548D70C0DQ34282823-BCA2E428-738B-4E39-AEAA-4D6B3EA7A344Q34291227-5BD9901B-CC6A-4461-950E-FECFF354A222Q34345987-4ADFA064-29E8-4237-9863-913B46900EFDQ34350664-CBCC12B8-4229-474D-94D9-9ECC66476858Q34633249-120B4A34-A535-47FF-9AB1-8CDFD86D7AC0Q34765478-27BA7E1F-8B36-46D0-9034-D1A3A370A9F0Q34952562-12E3C0F8-B509-4D3B-99D5-CA299B06030AQ35031497-7F0831D3-FF3A-4D0E-B7F8-9BC2C8840CC2Q35424070-9FB13F43-0A37-4BC8-BD78-CA5A52DBC416Q35649446-AD1CEBF8-92DD-49E4-ABEE-A761C1AC5008Q35663840-0AE19006-5B5E-4552-BFD3-E05F56597D61Q35802845-46C192CF-D55F-4B7D-8FAD-5823576B670EQ35816965-569A7368-E0EC-4C1D-82A5-CFDA94525961Q35847850-B18EFE15-130D-40B1-B8CD-76A2C2B58739Q36353294-AB97D438-2E26-4E02-878C-D9CD84A913CDQ36355057-A51D2AA5-8672-4B80-8841-C7CBACF5FC8AQ36364632-AB872E6D-7E35-46E2-AF20-DB12A2422FBA
P2860
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
@en
type
label
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
@en
prefLabel
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
@en
P2093
P356
P1433
P1476
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
@en
P2093
Brinster RL
Chisari FV
McLachlan A
Palmiter RD
Pinkert CA
P304
P356
10.1126/SCIENCE.3865369
P407
P577
1985-12-01T00:00:00Z